Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells - Sorbonne Université
Journal Articles Journal of Hepatology Year : 2012

Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells

Marie-José Blivet-van Eggelpoël
  • Function : Author
Hamza Chettouh
  • Function : Author
Laetitia Fartoux
  • Function : Author
Lynda Aoudjehane
  • Function : Author
Centre de Recherche Saint-Antoine
Véronique Barbu
  • Function : Author
Colette Rey
  • Function : Author
Sabrina Priam
  • Function : Author
Chantal Housset
  • Function : Author
Olivier Rosmorduc
  • Function : Author
Christèle Desbois-Mouthon
  • Function : Author

Domains

Life Sciences [q-bio]

Lynda Aoudjehane  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03979200

Submitted on : Wednesday, February 8, 2023-4:19:30 PM

Last modification on : Thursday, December 14, 2023-1:50:38 PM

No file

Dates and versions

hal-03979200 , version 1 (08-02-2023)

Identifiers

Cite

Marie-José Blivet-van Eggelpoël, Hamza Chettouh, Laetitia Fartoux, Lynda Aoudjehane, Véronique Barbu, et al.. Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells. Journal of Hepatology, 2012, 57 (1), pp.108-115. ⟨10.1016/j.jhep.2012.02.019⟩. ⟨hal-03979200⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

U938 SORBONNE-UNIVERSITE SU-MEDECINE
10 View
0 Download

Altmetric

Share

More